- Home
- GSIT vs NTHI Comparison
GSIT vs NTHI Comparison
Compare GSIT & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSIT
- NTHI
- Stock Information
- Founded
- GSIT 1995
- NTHI 2008
- Country
- GSIT United States
- NTHI United States
- Employees
- GSIT N/A
- NTHI N/A
- Industry
- GSIT Semiconductors
- NTHI Biotechnology: Pharmaceutical Preparations
- Sector
- GSIT Technology
- NTHI Health Care
- Exchange
- GSIT Nasdaq
- NTHI Nasdaq
- Market Cap
- GSIT 98.7M
- NTHI 110.9M
- IPO Year
- GSIT N/A
- NTHI N/A
- Fundamental
- Price
- GSIT $4.69
- NTHI $5.10
- Analyst Decision
- GSIT
- NTHI
- Analyst Count
- GSIT 0
- NTHI 0
- Target Price
- GSIT N/A
- NTHI N/A
- AVG Volume (30 Days)
- GSIT 411.4K
- NTHI 284.4K
- Earning Date
- GSIT 07-31-2025
- NTHI 01-01-0001
- Dividend Yield
- GSIT N/A
- NTHI N/A
- EPS Growth
- GSIT N/A
- NTHI N/A
- EPS
- GSIT N/A
- NTHI N/A
- Revenue
- GSIT $20,518,000.00
- NTHI $79,990.00
- Revenue This Year
- GSIT N/A
- NTHI N/A
- Revenue Next Year
- GSIT N/A
- NTHI N/A
- P/E Ratio
- GSIT N/A
- NTHI N/A
- Revenue Growth
- GSIT N/A
- NTHI 13.52
- 52 Week Low
- GSIT $1.62
- NTHI $3.20
- 52 Week High
- GSIT $5.89
- NTHI $25.00
- Technical
- Relative Strength Index (RSI)
- GSIT 55.91
- NTHI N/A
- Support Level
- GSIT $5.08
- NTHI N/A
- Resistance Level
- GSIT $5.89
- NTHI N/A
- Average True Range (ATR)
- GSIT 0.37
- NTHI 0.00
- MACD
- GSIT -0.02
- NTHI 0.00
- Stochastic Oscillator
- GSIT 38.78
- NTHI 0.00
About GSIT GSI Technology
GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia. In addition, it serves the ongoing needs of the military, aerospace, industrial, test and measurement equipment, and automotive and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and the United States.
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").